comparemela.com

Latest Breaking News On - Respiratory tract diseases - Page 4 : comparemela.com

Abbott Labs Posts Higher 4Q Sales, Despite Soft Demand For Covid Tests

By Will Feuer Abbott Laboratories posted higher sales in the fourth quarter, despite continued soft demand for the company's Covid-19 testing equipment. The.

Abbott laboratoriesAbbott parkWill feuerArticle normalHealthcare life sciencesFinancial performanceSales figuresCorporate industrial newsPolitical general newsRespiratory tract diseasesMedical conditionsOutbreaks epidemicsNovel coronavirusesInfectious diseasesContent typesFactiva filters

Abbott Labs Q4 sales top estimates amid strong medical-device demand

Abbott Laboratories on Wednesday reported fourth-quarter sales that topped expectations amid strength in its medical-device and nutrition segments.

San franciscoUnited statesRobert fordAbbott laboratorieEli lilly coTandem diabetes care incFreestyle libreTandem diabetes careNovo nordiskEli lillyArticle normalAgricultural machineryMedical equipment suppliesHealthcare life sciencesSpecialized drugs medicationsHormone products

Capricor Therapeutics Shares Rise 7% After Collaboration for Covid-19 Vaccine

By Chris Wack Capricor Therapeutics shares were up 7% at $4.42 after the company said its proprietary StealthX exosome-based multivalent vaccine for the.

Capricor stealthChris wackNational institute of allergyDivision of microbiologyNational institutes of healthHuman services departmentUs healthProject nextgenNational instituteInfectious diseasesNational institutesArticle normalBiotechnology servicesHealthcare life sciencesBiological therapySpecialized drugs medications

Gilead s stock tumbles toward biggest selloff in more than 9 years after lung cancer treatment trial disappoints

Shares of Gilead Sciences tumbled 9.7% early Monday after the company reported disappointing lung-cancer trial results.

Merdad parseyGilead sciences incGilead sciencesChief medical officer merdadArticle normalHealthcare life sciencesRegulation government policyFinancial performanceAnalysts amp 39 comments recommendationsShare price movement disruptionsOwnership changesAcquisitions mergers shareholdingsCorporate actionsCorporate industrial newsPolitical general newsRespiratory tract diseases

Peak China narrative is flawed, former Australian prime minister says

Kevin Rudd told the World Economic Forum he believes Chinese consumer demand has the potential to drive long term growth

Kevin ruddWorld economic forum in davosLabor partyFormer australian prime minister kevin ruddWorld economic forumArticle normalN aEconomic performance indicatorsEconomic growth recessionEconomic newsPolitical general newsRespiratory tract diseasesMedical conditionsOutbreaks epidemicsPolitics international relationsDomestic politics

vimarsana © 2020. All Rights Reserved.